This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during May 2024 (epidemiological weeks 18-22) Click
We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Click here to view PDF
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2024. Click here to view
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2023, with additional data from December
Serum-biomarkers of infection such as CRP and ESR and synovial fluid leucocyte count and neutrophil percentage are useful tests to support the diagnosis of PJI.